Bevacizumab-Adcd 32228-0020-01
- Manufacturer
- Celltrion, Inc
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- April 3, 2023
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bevacizumab-Adcd | 100 mg/4mL |
Selected Package
32228-0020-01Selected4 mL in 1 VIAL (32228-020-01)